Even if they don't do any more deals, somebody needs to manage out the existing VC portfolio and I doubt that anybody knows it as well as she does.
ACW This biotech stock raised $11M in a risk-off environment. Its Alzheimer's drug could change the game
History-making uranium sample grades and an imminent drill run. Infini Resources is poised to transform in 2025